Publications

  1. Gomez E, Kennedy CC, Gottschalk M, Cunningham SA, Patel R, Virk A. Streptococcus suis-related prosthetic joint infection and streptococcal toxic shock-like syndrome in a pig farmer in the United States. J Clin Microbiol. 2014 Jun; 52(6):2254-8. Epub 2014 Apr 09.
    View PubMed
  2. Frazee EN, Rule AD, Herrmann SM, Kashani KB, Leung N, Virk A, Voskoboev N, Lieske JC. Serum cystatin C predicts vancomycin trough levels better than serum creatinine in hospitalized patients: A cohort study. Crit. Care. 2014; 18(3):R110.
  3. Virk A, Mandrekar J, Berbari EF, Boyce TG, Fischer PR, Kasten MJ, Orenstein R, Rosenblatt JE, Sampathkumar P, Sia I, Springer D, Witzig TE. A randomized, double blind, placebo-controlled trial of an oral synbiotic (AKSB) for prevention of travelers' diarrhea. J Travel Med. 2013 Mar-Apr; 20(2):88-94. Epub 2013 Jan 25.
    View PubMed
  4. Alasmari FA, Tleyjeh IM, Riaz M, Greason KL, Berbari EF, Virk A, Baddour LM. Temporal trends in the incidence of surgical site infections in patients undergoing coronary artery bypass graft surgery: a population-based cohort study, 1993 to 2008. Mayo Clin Proc. 2012 Nov; 87(11):1054-61.
    View PubMed
  5. Agyemang EA, Virk A. 57-Year-old man with fever, rash, chronic watery diarrhea, cough, and sweats. Mayo Clin Proc. 2012 Nov; 87(11):e83-6.
    View PubMed
  6. El Helou OC, Berbari EF, Lahr BD, Eckel-Passow JE, Razonable RR, Sia IG, Virk A, Walker RC, Steckelberg JM, Wilson WR, Hanssen AD, Osmon DR. Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention. Eur J Clin Microbiol Infect Dis. 2010 Aug; 29(8):961-7. Epub 2010 May 27.
    View PubMed
  7. Berbari EF, Osmon DR, Carr A, Hanssen AD, Baddour LM, Greene D, Kupp LI, Baughan LW, Harmsen WS, Mandrekar JN, Therneau TM, Steckelberg JM, Virk A, Wilson WR. Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Clin Infect Dis. 2010 Jan 1; 50(1):8-16.
    View PubMed
  8. Tsigrelis C, Tleyjeh IM, Huskins WC, Lahr BD, Nyre LM, Virk A, Baddour LM. Incidence of invasive pneumococcal disease among children after introduction of a 7-valent pneumococcal conjugate vaccine: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc. 2009 Oct; 84(10):871-5.
    View PubMed
  9. Tsigrelis C, Tleyjeh IM, Lahr BD, Nyre LM, Virk A, Baddour LM. Trends in invasive pneumococcal disease among older adults in Olmsted County, Minnesota. J Infect. 2009 Sep; 59(3):188-93. Epub 2009 Jul 14.
    View PubMed
  10. Reyburn AM, Virk A. 22-year-old woman with fever and jaundice after travel to Ghana. Mayo Clin Proc. 2009 May; 84(5):461-4.
    View PubMed
  11. Sohail MR, Gray AL, Baddour LM, Tleyjeh IM, Virk A. Infective endocarditis due to Propionibacterium species. Clin Microbiol Infect. 2009 Apr; 15(4):387-94. Epub 2009 Mar 02.
    View PubMed
  12. Tsigrelis C, Tleyjeh IM, Lahr BD, Nyre LM, Virk A, Baddour LM. Decreases in case-fatality and mortality rates for invasive pneumococcal disease in Olmsted County, Minnesota, during 1995-2007: a population-based study. Clin Infect Dis. 2008 Dec 1; 47(11):1367-71.
    View PubMed
  13. Anastassiades CP, Virk A. From gut to bone. Am J Med. 2008 Sep; 121(9):767-9.
    View PubMed
  14. Uslan DZ, Patel R, Virk A. International travel and exposure risks in solid-organ transplant recipients. Transplantation. 2008 Aug 15; 86(3):407-12.
    View PubMed
  15. Lassmann B, Tsigrelis C, Virk A. 33-year-old woman with marked eosinophilia. Mayo Clin Proc. 2007 Jan; 82(1):103-6.
    View PubMed
  16. Uslan DZ, Kowalski TJ, Wengenack NL, Virk A, Wilson JW. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility. Arch Dermatol. 2006 Oct; 142(10):1287-92.
    View PubMed
  17. Tleyjeh IM, Georgescu G, Virk A, Barajas ED, Mirzoyev Z, Anavekar N, Baddour LM. Cytomegalovirus cholangitis presenting with recurrent hemobilia. Eur J Clin Microbiol Infect Dis. 2005 Sep; 24(9):634-6.
    View PubMed
  18. Uslan DZ, Virk A. Postexposure chemoprophylaxis for occupational exposure to human immunodeficiency virus in traveling health care workers. J Travel Med. 2005 Jan-Feb; 12(1):14-8.
    View PubMed
  19. Virk A, Fischer PR. Travel medicine: An American view of the Australian perspective. Travel Medicine & Infectious Disease. 2005; 3(2):77-9.
    View PubMed
  20. Meehan AM, Virk A, Swanson K, Poeschla EM. Severe pleuropulmonary paragonimiasis 8 years after emigration from a region of endemicity. Clin Infect Dis. 2002 Jul 1; 35(1):87-90.
    View PubMed
  21. Virk A. Medical advice for international travelers. Mayo Clin Proc. 2001 Aug; 76(8):831-40.
    View PubMed
  22. Virk A, Osmon DR. Prosthetic joint infection: Current treatment ooptions. Current Treatment Options in Infectious Diseases. 2001; 3(4):287-301.
  23. Virk A, Steckelberg JM. Clinical aspects of antimicrobial resistance. Mayo Clin Proc. 2000 Feb; 75(2):200-14.
    View PubMed
  24. Fischer PR, Virk A. Travel Advisory. In: Primary Care Reports. 1999.